Remove market-access views-analysis
article thumbnail

The immediate future of DTC

World of DTC Marketing

As we look forward to 2021 DTC marketers should be noting the changes in consumer attitudes and the way they request new treatments. DTC marketers need to fall out of love with TV and think about how they translate awareness into brand objectives. It largely depends on how big your market is and where they get their health information.

Doctors 296
article thumbnail

Add Relevance to Your Marketing Plan: The Value of Personalization and Localization

PM360

It’s more challenging than ever to be a pharma marketer. Rapid changes in the market resulting from COVID-19. healthcare professionals (HCPs) agree that pharma marketing provides a personalized and relevant experience (Figure 1). While this view is valid, the industry has evolved even further. What Is Local Marketing?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Unleashing the power of computational tools in rare disease

Clarivate

Data from a rising tide of sources can empower pharma executive decision making from R&D, clinical studies, health outcomes, drug safety, and market access. Bioinformatics tools facilitate the analysis of genomic data, including DNA sequencing, gene expression profiling, and variant annotation.

article thumbnail

Achieving commercial excellence with data-driven decisions

pharmaphorum

How can we maximise marketing, sales, medical, access, and other teams’ efforts while making their jobs easier? To be most effective, key commercial excellence data must live in a cloud-accessible database. Historically, competitive and market analysis data has been stored in spreadsheets. Who are your competitors?

article thumbnail

Real Chemistry and WhizAI Announce Partnership to Develop a Generative AI-Based Patient Journey Visualization and Analytics Solution

PM360

Real Chemistry , a leading provider of AI-driven insights and marketing and communications for the healthcare industry, is partnering with WhizAI , a generative AI-powered analytics platform purpose-built for life sciences and healthcare, to develop a patient journey visualization and analytics solution. Fisher explains. “We

article thumbnail

Strategies for Combination Therapy in Oncology: Part One – Business as Usual

PM360

In this article, we discuss the challenges and opportunities within the current landscape and key issues impacting pricing and access for combination therapy. From the manufacturer perspective, payer policies and legislation on combination therapy pricing are impacting global development, pricing, access, and commercialization strategies.

article thumbnail

4 Reasons Why Customer 360* is Important to Close More Deals

Toolyt

According to the study conducted by Gartner in 2022, only 14% of organizations have achieved a customer 360* view. In the current market trends, understanding what customers want from you paves the way to long-term success. An elaborately detailed view of the customer about his/her past and present interactions is important.

CRM 52